-

SHAREHOLDER ALERT: Labaton Sucharow Investigates Claims On Behalf of Investors of Athenex, Inc. (NASDAQ: ATNX)

NEW YORK--(BUSINESS WIRE)--Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against Athenex, Inc. (NASDAQ: ATNX).

Shares are down over 50% after the Company reported Q4 results and received a complete response letter from the FDA regarding its new drug application for oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The FDA expressed the following:

  • Concerns about safety risks associated with increase in neutropenia-related sequelae
  • Concerns regarding the primary endpoint assessment conducted by the Blinded Independent Central Review (BICR)
  • Recommendation that Athenex conduct a new clinical trial in a patient population with metastatic breast cancer representative of the population in the U.S.

If you currently own shares of ATNX and want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll-free number (800) 321-0476 or via email at dschwartz@labaton.com.

About the Firm

Labaton Sucharow LLP is one of the world’s leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.

Contacts

David J. Schwartz
(800) 321-0476
dschwartz@labaton.com

Labaton Sucharow

NASDAQ:ATNX

Release Versions

Contacts

David J. Schwartz
(800) 321-0476
dschwartz@labaton.com

More News From Labaton Sucharow

Partner Jesse L. Jensen Joins Labaton Keller Sucharow

NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP is pleased to announce that Jesse L. Jensen will be joining the Firm’s New York office as a Partner in the Firm’s Securities Litigation Practice Group. “Jesse is an exceptional litigator whose experience in high-stakes securities cases strengthens our already formidable team,” said Jonathan Gardner, Managing Partner and Head of Litigation. “His track record of achieving meaningful results for investors and his commitment to excellence make...

Labaton Keller Sucharow LLP Files Securities Class Action Against Avantor, Inc. and Certain of Its Executives

NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Action”) on behalf of its client the City of Pontiac Reestablished General Employees Retirement System (“Pontiac RGERS”) against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and certain of its executives (collectively, “Defendants”). The Action, which is captioned City of Pontiac Reestablished General Employees Retirement System v. Avantor, Inc., No. 25-cv-06686 (E.D....

Labaton Keller Sucharow LLP Files Securities Class Action Against Synopsys, Inc. and Certain of Its Executives

NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Complaint”) on behalf of its client the New England Teamsters Pension Fund (“New England Teamsters”) against Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) and certain of its executives (collectively, “Defendants”). The Action, which is captioned New England Teamsters Pension Fund v. Synopsys, Inc., No. 25-cv-10201 (N.D. Cal. Nov. 25, 2025), asserts claims under Sect...
Back to Newsroom